HORSE SPECIES SYMPOSIUM: Use of mesenchymal stem cells in fracture repair in horses.

The study explores the potential use of mesenchymal stem cells (MSCs) to effectively heal bone fractures in horses. It investigates both bone marrow and adipose-derived MSCs, which are said to have possible applications in improving fracture repairs and reducing reinjury chances in equine therapies.

Introduction

• This research focuses on the problem of equine bone fractures which often result in serious, potentially fatal consequences and are costly to handle. Traditional fracture healing methods often fall short in terms of efficiency and have been associated with lengthy recovery times and high reinjury rates.
• Stem cell therapy emerges as a promising avenue to enhance fracture healing and lower reinjury incidences. However, current information on its success in horses is limited and variable.

Use of Mesenchymal Stem Cells

• Mesenchymal stem cells (MSCs) can be produced from diverse sources which include embryonic, fetal, and adult tissues. Preference is given to adipose- or bone marrow-derived MSCs in equine therapies because of the ease of collection, availability of autologous cells, and the success witnessed in other models.
• The study highlights that the methods for obtaining, proliferating, and distinguishing MSCs is well outlined for rodent and human models but not for horses.
• Recent investigations have shown that equine bone marrow MSCs can multiply in culture for several rounds in the presence of autologous and fetal bovine serum, which is crucial for expanding cells.

Transcription Factors Involved

• The MSCs can morph into osteoblasts, cells responsible for forming bones. This intricate process is governed by several transcription factors, including runt-related transcription factor 2 (Runx2) and osterix (Osx). The study reflects on whether equine MSCs are regulated in a similar manner.
• Findings from the study support the view that equine bone marrow MSCs are influenced by the same transcription factors that guide the differentiation of rodent and human MSCs into osteoblasts.

Prospects and Challenges

• The paper acknowledges that stem cell therapy presents a promising opportunity to improve bone repair in horses. However, much work lies ahead in ascertaining the ideal methods for reintroducing cells into the body and potential ways to boost their bone-forming abilities.